Year: 2019

Statistically significant four-fold increase in progression free survival observed in women with high AVB-500 levelsAravive to Host Conference Call Today at 8 a.m. ESTHOUSTON, Nov. 20, 2019 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV) today announced new positive data from the ongoing Phase 1b portion of the Phase 1b/2 clinical trial of AVB-500 in platinum-resistant recurrent ovarian cancer patients. The data from the first 31 patients treated at the 10mg/kg dose are maturing and affirm earlier findings on the relationship between AVB-500 levels and anti-tumor response. In this data analysis, high serum drug levels of AVB-500 were strongly predictive of anti-tumor activity with statistically significant correlation to progression-free survival (PFS; p=0.0066). PFS is the primary endpoint for platinum-resistant ovarian cancer...

Safety and tolerability demonstrated in diverse patient populations and surgeriesCHESTERBROOK, Pa., Nov. 20, 2019 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced publication of results from the Phase 3 open-label safety study (ATHENA) for IV oliceridine in The Journal of Pain Research. The results highlight the safety and tolerability of oliceridine in the management of moderate-to-severe acute pain in a variety of surgical / medical settings and patient populations.The publication, “ATHENA: A Phase 3, Open Label Study of the Safety and Effectiveness of Oliceridine (TRV130), a G-Protein Selective Agonist at the µ-Opioid Receptor, in Patients with Moderate to Severe...

BOISE, Idaho, Nov. 20, 2019 (GLOBE NEWSWIRE) — On November 1, 2019, US Ecology, Inc. (the “Company”) completed a merger transaction (the “Merger”) in which the Company acquired NRC Group Holdings Corp. (“NRCG”). In the Merger, warrants to purchase shares of NRCG common stock, par value $0.0001, were converted into warrants to purchase shares of the Company’s common stock, par value $0.01 (the “ECOL Warrants”). In connection with the closing of the Merger, the ECOL Warrants were listed on the Nasdaq Global Select Market (“Nasdaq GS”) under the symbol “ECOLW.”On November 19, 2019, the Company notified Nasdaq that it intends to delist the ECOL Warrants from Nasdaq GS, effective prior to the open of trading on December 9, 2019, because the ECOL Warrants do not meet the minimum 400 round lot holder requirement for listing as set forth...

NEW YORK, Nov. 20, 2019 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), clinical-stage biopharmaceutical company, announced today the closing of its previously announced underwritten public offering with total gross proceeds of approximately $9,000,000 before deducting underwriting discounts, commissions and other offering expenses payable by the Company.The securities sold by the Company consist of (i) 547,420 Class A Units, each Class A Unit consisting of one share of common stock, par value $0.001 per share (the “Common Stock”), one Warrant (“Warrants”) to purchase one share of common stock and one-half of a Common Stock Purchase Warrant (“Common Stock Purchase Warrants”) to purchase one share of common stock at a price of $1.94 per Class A Unit and (ii) 7,938 Class B Units, each...

MINNEAPOLIS, Nov. 20, 2019 (GLOBE NEWSWIRE) — iMedia Brands, Inc. (NASDAQ: IMBI) today announced results for the third quarter ended November 2, 2019. Third Quarter 2019 Summary & Recent Operational HighlightsEPS improved 36% to $(0.09) compared to $(0.14) last year.Net loss improved 26% to $6.7 million compared to $9.2 million last year.Adjusted EBITDA improved 77% to $(986) thousand compared to $(4.2) million last year. Previous six month period Adjusted EBITDA loss of $14 million reduced to $775 thousand for the most recent six month period.Net sales of $115 million compares to $132 million last year, a 12.6% decline. Previous six month period revenue decline of 17.2% reduced to 12.7% for the most recent six months. Rebranded flagship network to ShopHQ.Secured exclusive relationships with seven new home and fashion brands:...

TORONTO, Nov. 20, 2019 (GLOBE NEWSWIRE) — Alacer Gold Corp. (“Alacer” or the “Corporation”) [TSX: ASR and ASX: AQG] is pleased to announce that the ongoing Ardich step-out drilling program confirms a significant extension of the mineralization. The interim Indicated Mineral Resource increased 28% to 816,600 contained gold ounces and the Inferred Mineral Resource increased by 519% to 593,900 contained gold ounces. Exploration has been focused on determining the extent of the viable mineralized target rather than infill drilling for resource conversion. Exploration continues and is being accelerated with 7 diamond drill rigs currently on site.The interim Mineral Resource extends approximately 1.4 km along a NW/SE strike, representing areas with enough drill density to define a resource. Surface mapping indicates the mineralized target...

LOS ANGELES, CA, Nov. 20, 2019 (GLOBE NEWSWIRE) — Oaktree Strategic Income Corporation (NASDAQ: OCSI) (“Oaktree Strategic Income” or the “Company”), a specialty finance company, today announced its financial results for the fiscal quarter and year ended September 30, 2019.Financial Highlights for the Quarter and Year Ended September 30, 2019Total investment income was $12.1 million ($0.41 per share) and $49.6 million ($1.68 per share) for the fourth fiscal quarter and the full year of 2019, respectively, as compared with $13.8 million ($0.47 per share) and $47.7 million ($1.62 per share) for the third fiscal quarter of 2019 and the full fiscal year of 2018, respectively. The increase in investment income for the full year was primarily due to a larger average investment portfolio and call protection fees earned on exits of certain...

LOS ANGELES, Nov. 20, 2019 (GLOBE NEWSWIRE) — Oaktree Specialty Lending Corporation (NASDAQ: OCSL) (“Oaktree Specialty Lending” or the “Company”), a specialty finance company, today announced its financial results for the fiscal quarter and year ended September 30, 2019.Financial Highlights for the Quarter and Year Ended September 30, 2019Total investment income was $34.5 million ($0.24 per share) and $147.7 million ($1.05 per share) for the fourth fiscal quarter and full fiscal year of 2019, respectively, as compared with $36.7 million ($0.26 per share) and $138.7 million ($0.98 per share) for the third fiscal quarter of 2019 and the full fiscal year of 2018, respectively. The increase in investment income for the full year was primarily due to higher levels of original issue discount (“OID”) accretion and call protection...

VANCOUVER, British Columbia, Nov. 20, 2019 (GLOBE NEWSWIRE) — Search Minerals Inc. (“Search” or the “Company”) (TSXV: “SMY”) is pleased to announce that the Company is conducting a non-brokered private placement of up to 10,000,000 flow-through common shares of the Company (the “Flow-Through Shares“) at a price of $0.05 per Flow-Through Share for maximum gross proceeds of up to $500,000 (the “Offering“).Proceeds from the Offering will be used to incur “Canadian exploration expenses”, as defined in the Income Tax Act (Canada), related to the Company’s mineral projects in the Critical Rare Earth Element District of South East Labrador (the “District”). In particular, the proceeds will be used towards a Phase 3 drill program at Deep Fox, and other exploration work in the District.The...